Moving personalized medicine from promise to practice. Siemens Healthcare announces the early study findings of a new imaging biomarker for hypoxic tumors. This clinically problematic cells tend to be less responsive to standard treatment regimens. A probe that measures hypoxia could prove quite a useful tool for oncologists.
People with diabetes are often interested to be involved in research trials, according to the patient organization UK Diabetes. Therefore, the Diabetes Research Network (DRN) announced an initiative which shall help diabetics to play a greater role in research.
New research claims that nearly four million people in the UK may be unaware they are at high risk of heart disease. An University of Oxford team screened more than 71,000 people aged over 18 across England, Wales and Scotland.
Transition Therapeutics Inc. announced that the first patient has been dosed in a Phase 2 clinical study of gastrin analogue, TT-223, in patients with type 2 diabetes. Gastrin based therapies are an emerging class of potential disease-modifying treatments for patients with diabetes.
Optimal treatment of diabetes is very difficult to achieve since many obstacles have to be overcome such as expensive treatments, poor patient compliance or insufficient datac. With these challenges in mind, a new research project titled "Computerassisted Diabetes Risk Management (CDRM)" was put in place to examine how eHealth solutions can improve diabetes care.
According to a study conducted by researchers at the University of Zurich and the Zurich University Hospital the answer is: Yes. They demonstrated that one injection per month sufficed to improve blood sugar levels significantly. Even more: The insulin production of the patients improved.
Experts starts to identify nutrition's components that might support the fight against diseases. Recently researchers from John Hopkins Medical School found that a decrease in lung concentrations of NFR2-dependent antioxidants, key components of the lung's defense system, is linked to the severity of chronic obstructive pulmany disease (COPD) in smokers.
There can be many reasons why a person might have relationship problems, but now Swedish scientists at Medical University Karolinska Institutet found a specific gene variant that is associated with how men bond to their partners. The insights can lead to a better understanding of such problems as autism and social phobia.
Accurate diagnostic analysis and staging of cancer of the bile duct still remains a challenge. According to a new study from Germany a new imaging system called Cellvizio allows physicians to examine tissue at the cellular level from inside the body may now enable them to diagnose one of the most difficult cancers to detect.
A unique experiment that compares single neuron firing during an activity and again as the activity is freely recalled as a memory shows what the brain looks like during spontaneous recollection.
A large-scale US study shows that obese people with asthma get hospitalised nearly 5 times more for the condition than non-obese sufferer from asthma. It is the first study excluding the other factors smoking, medication, gastroesophageal reflux and demographics.
Professor Tobias Back MD is medical director of the Clinic for Neurology and Neurological Intensive Medicine in Arnsdorf, Germany.
As an increasing number of international drug companies are moving their clinical trials business to India, the clinical trial industry has been raising concerns about the lack of regulation of private trials carried out there, including the uneven application of requirements for informed consent and proper ethics review.
Information in patients' records could benefit biomedical research in terms of understanding diseases and their treatments. The drawback is that those records contain confidential information that could identify patients. If that data has to be removed manually, the task is not only painstaking and therefore expensive, but also not foolproof.
To reduce health costs as well as improve health, many large employers and insurers are introducing pay for the performance of patients (P4P4P).
Seeking to set the agenda for urgent atrial fibrillation (AF) research, European and international cardiologists will gather this October at the European Heart House, in Sophia Antipolis, the headquarters of the European Society of Cardiology.
Cardiologist Dr Malissa Wood, of the Massachusetts General Hospital, Boston, USA, has reported that a study of Olympic athletes, using GE Healthcare's Vivid I cardiac compact ultrasound technology, has allowed the medical research team in Beijing to identify healthy patterns of heart enlargement that can differentiate it from hypertrophic cardiomyopathy.
Tumour cells can migrate, sometimes also during a surgery to remove the tumour. US researchers recently found, that perioperative treatment with a drug known as colchicine might protect against recurrences at the site of the surgical wound.
It was a mistery: Why didn't drugs which boost the tumor-killing power of immune cells in lab do well in clincal trials? Now researchers from Rockefeller University describe a way to enhance the ability of these drugs by combining them with radiation therapy.
The SlideCollector 48 enables the seamless integration of non-contact Laser Capture Microdissection (LCM) and single-cell AmpliGrid assay technology into one continuous, automated workflow. This ensures the highest levels of sample purity for applications in immunobiology, genetics, cancer research, stem cell research and forensics.
A Canadian study published in the New England Journal of Medicine concludes that chest pain in patients with heart disease could be treated as effective with medication over time as with an expensive angioplasty.
Experts on a US panel expressed their doubts on the beneficial quality of prostate cancer screenings for elderly men. Prostate cancer often grows very slowly and may not kill an older man before he suffers from another death reason, they pointed out.
From September onwards, Europe's largest academic health science partnership will start its programm in London, UK. Their focus will lay on preventing and treating major diseases in 10 key areas.
A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA.
They are one of the major threats in today's hospital: tiny pathogens that hide out in catheters, in ventilation tubes, on instruments or on the keyboards of medical technological equipment only waiting to attack patients whose immune system is already weakened. This week, EH Online will take a closer look at nosocomial infections, their causes, their effects and the available ways and means to…
